Advertisement
Research Article Free access | 10.1172/JCI118535
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Evers, R. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Zaman, G. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by van Deemter, L. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Jansen, H. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Calafat, J. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Oomen, L. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Oude Elferink, R. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Borst, P. in: JCI | PubMed | Google Scholar
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.
Find articles by Schinkel, A. in: JCI | PubMed | Google Scholar
Published March 1, 1996 - More info
The human multidrug resistance-associated protein MRP confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Recent evidence indicates that MRP can also transport glutathione S-conjugates across membranes. To study the transport properties of MRP in intact cells, we have expressed human MRP cDNA in the polarized pig kidney epithelial cell line LLC-PK1. MRP mainly localized to the basolateral plasma membrane of these cells, and not to the apical membrane, as determined by immunocytochemistry using confocal laser scanning and electron microscopy. In accordance with this localization, MRP caused increased transport of the glutathione S-conjugate S-(2, 4-dinitrophenyl)-glutathione and of the anticancer drug daunorubicin to the basal side of the epithelial cell layer. Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport, inhibited this basolateral transport, but not the apical transport of daunorubicin mediated by the apically localized human MDR1 P-glycoprotein in MDR1-transfected LLC-PK1 cells. Probenecid and sulfinpyrazone may therefore be useful lead compounds for the development of clinical reversal agents specific for MRP-mediated drug resistance.